Learn how FDA’s interchangeable ranibizumab biosimilar may streamline injections, cut costs, and guide safe switching for retina patients. Following the FDA approval of ranibizumab-hkdz (Ranluspec; ...
SOL-1 data show OTX-TKI extends rescue-free control in treatment-naive wet AMD, shaping AI-driven trial design and longer-interval care. Barakat opened by highlighting what makes CTS uniquely valuable ...
The US Food and Drug Administration (FDA) issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and ...
Meeting founder and co-chair Arshad M. Khanani, MD, MA, FASRS, shares what attendees can expect during this year's program, opening the evening of June 12 and running through June 13 in Las Vegas, ...
Alkeus Pharmaceuticals has dosed the first participant in the phase 3 NORTHSTAR trial of oral gildeuretinol for Stargardt disease, a condition with no approved treatments. Alkeus Pharmaceuticals in a ...
Patent milestones: granted in Singapore; notices of allowance in Canada and Japan; applications pending in Europe, the US, India, and South Korea. Technology: induced pluripotent stem cells-derived ...
ipRGC dysfunction may contribute to early Alzheimer's disease manifestations. The study suggests that alterations in intrinsically photosensitive retinal ganglion cells (ipRGCs), which regulate ...
A retrospective study identifies thin choroid as the key factor behind ungradable ultrawidefield green-light fundus autofluorescence images in geographic atrophy. This retrospective, cross-sectional ...
Researchers report pseudophakic patients implanted with a peripheral vision IOL detected roadway hazards significantly faster than those receiving a standard monofocal lens.
Researchers report pseudophakic patients implanted with a peripheral vision IOL detected roadway hazards significantly faster than those receiving a standard monofocal lens.
Mark Barakat, MD, is a vitreoretinal surgeon and director of research at the Retina Macula Institute of Arizona, where he specializes in the surgical and medical management of complex retinal diseases ...
Researchers report pseudophakic patients implanted with a peripheral vision IOL detected roadway hazards significantly faster than those receiving a standard monofocal lens.